FierceBiotech Executive Breakfast- Tackling the Drug Price Problem: A Town Hall Debate

Drug pricing has taken over the public debate about the biopharma industry. Companies are facing renewed questions about whether drug prices are fair, while the industry argues that the cost of R&D justifies the price of new drugs. RSVP today for this town-hall-style discussion with a panel of expert guests!